Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,897 | 607 | 99.9% |
| Education | $6.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,782 | 122 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $868.10 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $810.77 | 59 | $0 (2024) |
| PFIZER INC. | $759.79 | 61 | $0 (2024) |
| Amgen Inc. | $731.27 | 58 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $707.60 | 40 | $0 (2022) |
| Lilly USA, LLC | $588.48 | 42 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $471.75 | 32 | $0 (2024) |
| Merck Sharp & Dohme LLC | $337.09 | 40 | $0 (2023) |
| ABBVIE INC. | $327.97 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,478 | 85 | Novo Nordisk Inc ($379.54) |
| 2023 | $1,553 | 99 | Novo Nordisk Inc ($474.72) |
| 2022 | $1,236 | 83 | Novo Nordisk Inc ($260.73) |
| 2021 | $1,098 | 65 | Novo Nordisk Inc ($351.68) |
| 2020 | $541.91 | 34 | Amgen Inc. ($113.61) |
| 2019 | $1,157 | 91 | PFIZER INC. ($207.56) |
| 2018 | $1,034 | 77 | PFIZER INC. ($298.14) |
| 2017 | $804.23 | 74 | Novo Nordisk Inc ($153.86) |
All Payment Transactions
608 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Obesity | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Respiratory | ||||||
| 10/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 09/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: Biological | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: PAIN | ||||||
| 08/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,573 | 4,561 | $411,533 | $159,926 |
| 2022 | 43 | 2,743 | 4,545 | $405,782 | $154,783 |
| 2021 | 36 | 2,449 | 3,930 | $364,456 | $144,520 |
| 2020 | 33 | 1,858 | 3,152 | $328,084 | $117,704 |
All Medicare Procedures & Services
145 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 262 | 590 | $116,230 | $41,824 | 36.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 209 | 209 | $49,533 | $25,051 | 50.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 78 | 370 | $41,810 | $20,001 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 237 | $31,521 | $11,719 | 37.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 112 | 112 | $15,433 | $8,010 | 51.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 69 | 80 | $15,120 | $7,767 | 51.4% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 46 | 48 | $16,896 | $6,709 | 39.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 206 | 393 | $22,401 | $5,103 | 22.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $5,352 | $4,968 | 92.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 270 | 597 | $12,537 | $4,958 | 39.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 219 | 356 | $13,528 | $3,649 | 27.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 114 | 114 | $4,104 | $3,242 | 79.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 235 | 410 | $14,350 | $3,098 | 21.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 13 | $4,074 | $1,914 | 47.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 61 | 116 | $8,468 | $1,909 | 22.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 83 | 165 | $7,095 | $1,556 | 21.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 62 | 62 | $5,704 | $1,173 | 20.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 59 | 113 | $4,520 | $998.92 | 22.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 22 | $1,738 | $846.78 | 48.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 12 | $1,080 | $782.38 | 72.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 90 | $3,780 | $718.29 | 19.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 29 | 35 | $3,185 | $686.48 | 21.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 22 | $1,320 | $634.83 | 48.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 54 | 65 | $2,080 | $538.85 | 25.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $612.00 | $483.48 | 79.0% |
About Dr. Bruce Brown, M.D
Dr. Bruce Brown, M.D is a Family Medicine healthcare provider based in Union City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942280243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Brown, M.D has received a total of $8,903 in payments from pharmaceutical and medical device companies, with $1,478 received in 2024. These payments were reported across 608 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($8,897).
As a Medicare-enrolled provider, Brown has provided services to 9,623 Medicare beneficiaries, totaling 16,188 services with total Medicare billing of $576,934. Data is available for 4 years (2020–2023), covering 145 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Union City, TN
- Active Since 01/20/2006
- Last Updated 05/08/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1942280243
Products in Payments
- XARELTO (Drug) $680.82
- Ozempic (Drug) $496.36
- TRADJENTA (Drug) $445.79
- FARXIGA (Drug) $430.80
- Rybelsus (Drug) $386.24
- JARDIANCE (Drug) $370.21
- Wegovy (Drug) $348.19
- Otezla (Drug) $345.38
- TRINTELLIX (Drug) $334.01
- BREZTRI (Drug) $270.29
- MOUNJARO (Drug) $248.14
- TRULICITY (Drug) $234.97
- LYRICA (Drug) $219.55
- CHANTIX (Drug) $208.64
- JANUVIA (Drug) $190.94
- Saxenda (Drug) $178.65
- EVENITY (Biological) $177.41
- UBRELVY (Drug) $162.00
- RYBELSUS (Drug) $159.36
- ENTRESTO (Drug) $146.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Union City
Dr. Jerry Jurado, M.d, M.D
Family Medicine — Payments: $63,292
Francisco Gonzalez, Md, MD
Family Medicine — Payments: $14,250
John Clendenin, M.d, M.D
Family Medicine — Payments: $11,619
John Hale, M.d, M.D
Family Medicine — Payments: $11,378
William Stone, M.d, M.D
Family Medicine — Payments: $11,291
Maria Paschalidis, D.o, D.O
Family Medicine — Payments: $10,936